Quality of life issues following autologous bone marrow transplantation

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 2, Issue 2, 2002, Pages 129-146

  Carlson, Linda E ^a   MacRae, J Helen ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anxiety; Autologous bone marrow transplantation; Autologous peripheral stem cell transplantation; Breast cancer; Fatigue; Leukemia; Lymphoma; Psychosocial interventions; QoL; Sexuality

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CANCER; CONTROLLED STUDY; EMOTION; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HUMAN; INTERMETHOD COMPARISON; MALE; MALIGNANT NEOPLASTIC DISEASE; MASTECTOMY; MEDICAL RESEARCH; PHYSICAL CAPACITY; QUALITY OF LIFE; REVIEW; SOCIAL ASPECT; SOLID TUMOR; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0036073107     PISSN: 14737167     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737167.2.2.129     Document Type: Review

References (82)

1. Psychosocial adaptation after bone marrow transplantation (BMT)
2. The meaning of cancer therapy: Bone marrow transplantation as an exemplar of therapy
3. Mood, coping style and personality functioning among adult bone marrow transplant candidates
4. Coping patterns among bone marrow transplant patients: A hermeneutical inquiry
5. QoL of 125 adults surviving 6-28 years after bone marrow transplantation
6. Personal changes, dispositional optimism and psychological adjustment to bone marrow transplantation
7. Positive and negative psychosocial sequelae of bone marrow transplantation: Implications for QoL assessment
8. Psychosocial morbidity and survival in adult bone marrow transplant recipients-a follow-up study
9. Coping with the physical and psychosocial sequelae of bone marrow transplantation among long-term survivors
10. High-dose chemotherapy for high-risk primary breast cancer: An on-site review of the Bezwoda study
11. Bezwoda: Evidence of fabrication in original article
12. Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer
13. ABMT and breast cancer: What have we learned?
14. High dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer
15. Fatigue and QoL in breast cancer patients undergoing autologous stem cell transplantation: A longitudinal comparative study
16. Fatigue in women treated with bone marrow transplantation for breast cancer: A comparison with women with no history of cancer
17. QoL in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support
18. The effectiveness of the comprehensive coping strategy program on clinical outcomes in breast cancer autologous bone marrow transplantation
19. High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: Does impact on QoL jeopardize feasibility and acceptability of treatment?
20. Longitudinal effects of high-dose chemotherapy and autologous stem cell transplantation on QoL in the treatment of metastatic breast cancer
21. QoL in breast cancer patients before and after autologous bone marrow transplantation
22. The psychosocial experience of women treated for breast cancer by high-dose chemotherapy supported by autologous stem cell transplant: A qualitative analysis of support groups
23. Health-related QoL in women with breast cancer undergoing autologous stem-cell transplantation
24. QoL of long-term adult survivors of autologous bone marrow transplantation
25. High level of fatigue in lymphoma patients treated with high dose therapy
26. QoL following bone marrow transplantation: Findings from a multicentre study
27. Patients' psychosocial concerns following stem cell transplantation
28. Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone
29. QoL in adult patients after stem cell transplantation
30. Do patients who are treated with stem cell transplantation have a health-related QoL comparable to the general population after 1 year?
31. QoL in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: A cross-sectional study of the EORTC-GIMEMA AML 8A trial
32. Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies
33. Relation of psychological vulnerability factors to posttraumatic stress disorder symptomatology in bone marrow transplant recipients
34. A retrospective study of psychosocial morbidity in bone marrow transplant recipients
35. Positive and negative psychosocial sequelae of bone marrow transplantation: Implications for QoL assessment
36. Time after bone marrow transplantation as an important variable for QoL: Results of a cross-sectional investigation using two different instruments for quality-of-life assessment
37. Conditional and unconditional estimation of multidimensional QoL after hematopoietic stem cell transplantation: A longitudinal follow-up of 415 patients
38. Longitudinal study of adaptation to the stress of bone marrow transplantation
39. Assessment of QoL during intensive chemotherapy or bone marrow transplantation
40. Evaluation of the neurobehavioral functioning of patients before, during and after bone marrow transplantation
41. Health-related QoL 1 year after allogeneic or autologous stem-cell transplantation: A prospective study
42. Psychological functioning and QoL following bone marrow transplantation: A 3-year follow-up study
43. Psychologic and neuropsychologic impact of autologous bone marrow transplantation
44. Psychological stress symptoms before and after autologous bone marrow transplantation in patients with solid tumors
45. Pain and psychological distress in patients undergoing autologous bone marrow transplantation
46. Post-traumatic stress symptoms in patients undergoing autologous stem cell transplantation
47. QoL and psychological distress of bone marrow transplant recipients: The 'time trajectory' to recovery over the first year
48. Physical exercise and QoL in cancer patients following high dose chemotherapy and autologous bone marrow transplantation
49. Bone Marrow Transplantation
50. Psychosocial factors in bone marrow transplantation: A review and recommendations for research
51. Psychosocial sequelae of bone marrow transplantation
52. QoL in adult bone marrow transplant patients: Beyond the first year
53. Identifying the types of missingness in QoL data from clinical trials
54. Why are missing QoL data a problem in clinical trials of cancer therapy?
55. Cost analysis and QoL assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or a prospective randomised trial
56. Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved QoL and cost reduction compared with bone marrow study
57. Hypnosis in the management of pain of oral mucositis associated with high dose therapy for cancer
58. Art therapy with adult bone marrow transplant patients in isolation: A pilot study
59. Development of an art program on a bone marrow transplant unit
60. Psychological and social preparation for bone marrow transplantation
61. Psychotherapy in early phases of oncological disease: A study of allogenic bone marrow transplanted patients
62. Trauma-focused intervention after bone marrow transplantation: A case study
63. Supportive psychotherapy combined with autogenous training in acute leukemic patients with isolation therapy
64. Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: A controlled clinical trial
65. Symptom distress, coping style and biological variables as predictors of survival after bone marrow transplantation
66. QoL-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission
67. Impact of a Group Psychosocial Intervention on Healthcare Utilization by Breast Cancer Patients
68. QoL following bone marrow transplantation for breast cancer: A comparative study
69. Posttraumatic stress disorder in breast cancer patients following autologous bone marrow transplantation or conventional cancer treatments
70. Acquiescence to adjunctive experimental therapies may relate to psychological distress: Pilot data from a bone marrow transplant center
71. Health-related QoL in women with breast cancer undergoing autologous stem-cell transplantation
72. Psychological support to an autologous bone marrow transplant unit in a community hospital: A pilot experience
73. QoL in adult recipients of bone marrow transplantation
74. Do patients who are treated with stem cell transplantation have a health-related QoL comparable to the general population after 1 year?
75. Patient reports of complications of bone marrow transplantation
76. Hope among patients with cancer hospitalized for bone marrow transplantation: A phenomenologic study
77. Dynamic assessment of QoL after autologous bone marrow transplantation
78. A comparison of in-patient and out-patient ASCT
79. Health-related QoL 1 year after allogeneic or autologous stem-cell transplantation: A prospective study
80. Reintegration after bone marrow transplantation
81. Psychological risk factors and early complications after bone marrow transplantation in adults